For: | Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW. Second primary malignancy risk after radiotherapy in rectal cancer survivors. World J Gastroenterol 2018; 24(40): 4586-4595 [PMID: PMC6209568 DOI: 10.3748/wjg.v24.i40.4586] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v24/i40/4586.htm |
Number | Citing Articles |
1 |
Xu Guan, Ran Wei, Runkun Yang, Zhao Lu, Enrui Liu, Zhixun Zhao, Haipeng Chen, Ming Yang, Zheng Liu, Zheng Jiang, Xishan Wang. Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms. JAMA Network Open 2021; 4(1): e2031661 doi: 10.1001/jamanetworkopen.2020.31661
|
2 |
Shuofeng Li, Ran Wei, Guanhua Yu, Hengchang Liu, Tianli Chen, Xu Guan, Xishan Wang, Zheng Jiang. Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.982792
|
3 |
Philipp Schubert, Vratislav Strnad, Thomas Weißmann, Claudia Schweizer, Michael Lotter, Stephan Kreppner, Andre Karius, Rainer Fietkau, Ricarda Merten. Protocol-based CT-guided brachytherapy for patients with prostate cancer and previous rectal extirpation—a curative approach. Strahlentherapie und Onkologie 2025; 201(1): 20 doi: 10.1007/s00066-024-02266-y
|
4 |
Xu Guan, Ran Wei, Runkun Yang, Zhao Lu, Enrui Liu, Zhixun Zhao, Haipeng Chen, Ming Yang, Zheng Liu, Zheng Jiang, Xishan Wang. Risk and Prognosis of Secondary Bladder Cancer After Radiation Therapy for Rectal Cancer: A Large Population-Based Cohort Study. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.586401
|
5 |
R. Böthig, W. Schöps, M. Zellner, K. Fiebag, B. Kowald, S. Hirschfeld, R. Thietje, I. Kurze, H. Böhme, A. Kaufmann, O. Jungmann, J. Zumbé, D. Porres, G. Lümmen, M. Nehiba, T. Kadhum, M. Forchert, K. Golka. Harnblasenkarzinom als Spätfolge einer Querschnittlähmung. Der Urologe 2020; 59(6): 700 doi: 10.1007/s00120-020-01124-w
|
6 |
Li Wen, Guansheng Zhong, Min Ren. Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-05126-w
|
7 |
Yi-Ting Lin, Michael Tian-Shyug Lee, Yen-Chun Huang, Chih-Kuang Liu, Yi-Tien Li, Mingchih Chen. Prediction of recurrence-associated death from localized prostate cancer with a charlson comorbidity index–reinforced machine learning model. Open Medicine 2019; 14(1): 593 doi: 10.1515/med-2019-0067
|
8 |
Radoslaw Pach, Piotr Richter, Marek Sierzega, Natalia Papp, Antoni Szczepanik. Preoperative Short-Course Radiotherapy and Surgery versus Surgery Alone for Patients with Rectal Cancer: A Propensity Score-Matched Analysis at 18-Year Follow-Up. Biomedicines 2021; 9(7): 725 doi: 10.3390/biomedicines9070725
|
9 |
Shinya Abe, Hiroaki Nozawa, Kazuhito Sasaki, Koji Murono, Shigenobu Emoto, Yuichiro Yokoyama, Hiroyuki Matsuzaki, Yuzo Nagai, Yuichiro Yoshioka, Takahide Shinagawa, Hirofumi Sonoda, Soichiro Ishihara. Sarcopenia is Associated With Oncological Prognosis and the Incidence of Secondary Cancer in Patients With Middle/Lower Rectal Cancer. Clinical Colorectal Cancer 2023; 22(1): 143 doi: 10.1016/j.clcc.2022.10.001
|
10 |
Yu‐Mei Kang, Tze‐Fan Chao, Ti‐Hao Wang, Yu‐Wen Hu. Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study. Cancer Medicine 2019; 8(8): 3639 doi: 10.1002/cam4.2030
|
11 |
Koji Matsuo, Andrew Vallejo, Syem K. Barakzai, David J. Nusbaum, Hiroko Machida, Marcia A. Ciccone, Lynda D. Roman. Secondary ovarian cancer after external beam radiotherapy for nonovarian pelvic malignancy. European Journal of Surgical Oncology 2023; 49(2): 461 doi: 10.1016/j.ejso.2022.08.025
|
12 |
Stefanos Kachris, Michalis Mazonakis. Radiotherapy for Rectal Cancer and Radiation-Induced Malignancies from Epidemiological and Dosimetric Data. Applied Sciences 2024; 14(24): 12063 doi: 10.3390/app142412063
|
13 |
Anne Schlesinger-Raab, Gabriele Schubert-Fritschle, Mia Kim, Jens Werner, Claus Belka, Hendrik Wolff, Ayman Agha, Martin Fuchs, Helmut Friess, Stefanie Combs, Barbara Häussler, Jutta Engel, Kathrin Halfter. Secondary Primary Cancer Risk After Radiation Therapy in Rectal Cancer: A Population-Based Cohort Study With Propensity Score Matching. Clinical Colorectal Cancer 2023; 22(4): 485 doi: 10.1016/j.clcc.2023.07.007
|
14 |
Manabu Kakizoe, Jun Watanabe, Koki Goto, Yusuke Suwa, Kazuya Nakagawa, Hirokazu Suwa, Mayumi Ozawa, Atsushi Ishibe, Mitsuyoshi Ota, Chikara Kunisaki, Itaru Endo. Identification of Patients with Locally Advanced Rectal Cancer in Whom Preoperative Radiotherapy Can Be Omitted: A Multicenter Retrospective Study at Yokohama Clinical Oncology Group (YCOG1307). Journal of the Anus, Rectum and Colon 2021; 5(2): 173 doi: 10.23922/jarc.2020-084
|
15 |
Liyu Liu, Bolin Chen. Influence factors of the survival in colorectal cancer patients with second primary malignancy after surgery: A SEER database analysis. Medicine 2023; 102(40): e35286 doi: 10.1097/MD.0000000000035286
|
16 |
You Mo, Minxin Chen, Meng Wu, Dawei Chen, Jinming Yu. Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.918137
|
17 |
Lei Song, Fei Zhao, Lijing Zhang, Zhifang Zhao, Long Jin, Yu Zhao, Jin Zhao. Analyzing risk factors for second malignancies in early gastric carcinoma from the SEER database. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68776-y
|
18 |
Xiaoxian Ye, Yinuo Tan, Ruishuang Ma, Pengrong Lou, Ying Yuan. Radiation Therapy Changed the Second Malignancy Pattern in Rectal Cancer Survivors. Medicina 2023; 59(8): 1463 doi: 10.3390/medicina59081463
|